
Leland Gershell
Stock Analyst at Oppenheimer
(3.90)
# 1,889
Out of 5,184 analysts
735
Total ratings
37.8%
Success rate
4.6%
Average return
Main Sectors:
Stocks Rated by Leland Gershell
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LXEO Lexeo Therapeutics | Reiterated: Buy | $20 | $3.07 | +551.47% | 5 | Nov 12, 2026 | |
| CAPR Capricor Therapeutics | Reiterated: Buy | $54 | $11.22 | +381.28% | 29 | Nov 11, 2026 | |
| PALI Palisade Bio | Reiterated: Buy | $8 | $1.17 | +583.76% | 4 | Nov 11, 2026 | |
| CGEN Compugen | Reiterated: Buy | $4 | $2.09 | +91.39% | 5 | Nov 10, 2026 | |
| XERS Xeris Biopharma Holdings | Reiterated: Buy | $18 → $21 | $16.52 | +27.12% | 12 | Nov 6, 2026 | |
| URGN UroGen Pharma | Reiterated: Buy | $60 | $26.10 | +129.89% | 50 | Nov 5, 2026 | |
| BMRN BioMarin Pharmaceutical | Reiterated: Buy | $97 → $94 | $58.33 | +61.15% | 40 | Nov 3, 2026 | |
| LGND Ligand Pharmaceuticals | Reiterated: Buy | $326 → $346 | $316.83 | +9.21% | 5 | Oct 30, 2026 | |
| AARD Aardvark Therapeutics | Downgraded: Hold | n/a | $1.59 | - | 3 | Oct 26, 2026 | |
| AVTX Avalo Therapeutics | Reiterated: Buy | $35 → $16 | $8.51 | +88.01% | 29 | Oct 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,038 | $977.58 | +6.18% | 21 | Oct 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.9604 | +941.23% | 3 | Sep 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $262 → $312 | $259.28 | +20.33% | 38 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $230 | $46.20 | +397.84% | 6 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 | $1.42 | +392.96% | 4 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $14 | $3.36 | +316.67% | 3 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $12.25 | +46.94% | 6 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $54 | $37.04 | +45.79% | 9 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $25 | $14.82 | +68.75% | 18 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.80 | - | 8 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.74 | - | 2 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $3.11 | +350.16% | 7 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $28 | $2.62 | +968.70% | 21 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.24 | +706.45% | 16 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $31.25 | - | 34 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $2.14 | +1,068.22% | 44 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $18.66 | - | 7 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $112.16 | n/a | 6 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $80 | $21.96 | n/a | 1 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $490 | $159.85 | n/a | 42 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $0.9398 | n/a | 20 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $106 | $58.53 | n/a | 3 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $1.02 | n/a | 19 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.23 | n/a | 17 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $0.6622 | n/a | 19 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.86 | n/a | 16 | Jul 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.20 | n/a | 6 | Oct 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $0.10 | n/a | 11 | May 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $200 | $0.000001 | n/a | 11 | Mar 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.00 | n/a | 16 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $0.0078 | n/a | 1 | Jun 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 | $0.30531 | n/a | 11 | Jun 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 | $1.00 | n/a | 16 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $42 | $1.35 | n/a | 7 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.0004 | n/a | 4 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $13.19 | n/a | 22 | Dec 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $11.71 | n/a | 13 | Dec 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.481 | n/a | 9 | Dec 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0061 | n/a | 15 | Sep 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.9851 | n/a | 3 | May 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.05 | n/a | 9 | May 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $5.55 | n/a | 9 | Apr 3, 2019 |
Lexeo Therapeutics
Nov 12, 2026
Reiterated: Buy
Price Target: $20
Current: $3.07
Upside: +551.47%
Capricor Therapeutics
Nov 11, 2026
Reiterated: Buy
Price Target: $54
Current: $11.22
Upside: +381.28%
Palisade Bio
Nov 11, 2026
Reiterated: Buy
Price Target: $8
Current: $1.17
Upside: +583.76%
Compugen
Nov 10, 2026
Reiterated: Buy
Price Target: $4
Current: $2.09
Upside: +91.39%
Xeris Biopharma Holdings
Nov 6, 2026
Reiterated: Buy
Price Target: $18 → $21
Current: $16.52
Upside: +27.12%
UroGen Pharma
Nov 5, 2026
Reiterated: Buy
Price Target: $60
Current: $26.10
Upside: +129.89%
BioMarin Pharmaceutical
Nov 3, 2026
Reiterated: Buy
Price Target: $97 → $94
Current: $58.33
Upside: +61.15%
Ligand Pharmaceuticals
Oct 30, 2026
Reiterated: Buy
Price Target: $326 → $346
Current: $316.83
Upside: +9.21%
Aardvark Therapeutics
Oct 26, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.59
Upside: -
Avalo Therapeutics
Oct 26, 2026
Reiterated: Buy
Price Target: $35 → $16
Current: $8.51
Upside: +88.01%
Oct 23, 2026
Reiterated: Buy
Price Target: $1,038
Current: $977.58
Upside: +6.18%
Sep 29, 2026
Reiterated: Buy
Price Target: $10
Current: $0.9604
Upside: +941.23%
Sep 2, 2026
Reiterated: Buy
Price Target: $262 → $312
Current: $259.28
Upside: +20.33%
Aug 25, 2026
Reiterated: Buy
Price Target: $230
Current: $46.20
Upside: +397.84%
Aug 14, 2026
Rated: Buy
Price Target: $7
Current: $1.42
Upside: +392.96%
Aug 14, 2026
Reiterated: Buy
Price Target: $30 → $14
Current: $3.36
Upside: +316.67%
Aug 7, 2026
Reiterated: Buy
Price Target: $18
Current: $12.25
Upside: +46.94%
Aug 7, 2026
Reiterated: Buy
Price Target: $54
Current: $37.04
Upside: +45.79%
Aug 7, 2026
Reiterated: Buy
Price Target: $24 → $25
Current: $14.82
Upside: +68.75%
Jun 22, 2026
Rated: Hold
Price Target: n/a
Current: $1.80
Upside: -
Jun 22, 2026
Rated: Hold
Price Target: n/a
Current: $3.74
Upside: -
Jun 15, 2026
Reiterated: Buy
Price Target: $14
Current: $3.11
Upside: +350.16%
May 20, 2026
Reiterated: Buy
Price Target: $25 → $28
Current: $2.62
Upside: +968.70%
May 15, 2026
Reiterated: Buy
Price Target: $10
Current: $1.24
Upside: +706.45%
Apr 13, 2026
Rated: Hold
Price Target: n/a
Current: $31.25
Upside: -
Feb 12, 2026
Reiterated: Buy
Price Target: $25
Current: $2.14
Upside: +1,068.22%
Feb 10, 2026
Rated: Hold
Price Target: n/a
Current: $18.66
Upside: -
Nov 4, 2025
Downgraded: Hold
Price Target: n/a
Current: $112.16
Upside: n/a
Sep 3, 2025
Initiated Coverage: Buy
Price Target: $80
Current: $21.96
Upside: n/a
Aug 4, 2025
Upgraded: Buy
Price Target: $490
Current: $159.85
Upside: n/a
Sep 16, 2024
Reiterated: Buy
Price Target: $25
Current: $0.9398
Upside: n/a
May 14, 2024
Reiterated: Buy
Price Target: $106
Current: $58.53
Upside: n/a
Mar 28, 2024
Initiated Coverage: Buy
Price Target: n/a
Current: $1.02
Upside: n/a
Dec 18, 2023
Reiterated: Buy
Price Target: n/a
Current: $3.23
Upside: n/a
Nov 13, 2023
Reiterated: Buy
Price Target: $11
Current: $0.6622
Upside: n/a
Jul 10, 2023
Reiterated: Buy
Price Target: n/a
Current: $1.86
Upside: n/a
Oct 4, 2022
Downgraded: Hold
Price Target: n/a
Current: $4.20
Upside: n/a
May 26, 2022
Reiterated: Buy
Price Target: $60
Current: $0.10
Upside: n/a
Mar 21, 2022
Reiterated: Buy
Price Target: $70 → $200
Current: $0.000001
Upside: n/a
Nov 16, 2021
Reiterated: Hold
Price Target: n/a
Current: $4.00
Upside: n/a
Jun 4, 2021
Initiated Coverage: Buy
Price Target: $8
Current: $0.0078
Upside: n/a
Jun 2, 2021
Rated: Buy
Price Target: $12
Current: $0.30531
Upside: n/a
May 18, 2021
Rated: Buy
Price Target: $7
Current: $1.00
Upside: n/a
May 7, 2021
Initiated Coverage: Buy
Price Target: $42
Current: $1.35
Upside: n/a
May 6, 2021
Reiterated: Hold
Price Target: n/a
Current: $0.0004
Upside: n/a
Dec 31, 2020
Rated: Hold
Price Target: n/a
Current: $13.19
Upside: n/a
Dec 31, 2020
Rated: Hold
Price Target: n/a
Current: $11.71
Upside: n/a
Dec 31, 2020
Rated: Hold
Price Target: n/a
Current: $0.481
Upside: n/a
Sep 11, 2020
Rated: Hold
Price Target: n/a
Current: $0.0061
Upside: n/a
May 10, 2019
Reiterated: Buy
Price Target: $7
Current: $0.9851
Upside: n/a
May 9, 2019
Rated: Hold
Price Target: n/a
Current: $1.05
Upside: n/a
Apr 3, 2019
Reiterated: Buy
Price Target: $8
Current: $5.55
Upside: n/a